Physician

Andrew Glenn Cheek, MD

According to 2025 Medicare claims, Andrew Cheek, MD (NPI: 1790979383) practices ophthalmology in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is SPOKANE EYE CLINIC PS (NPI: 1730187899; TIN: 910852217) and primary practice location at 99204-2509.

Cheek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 709 traditional Medicare patients, billed 71,343 HCPCS/CPT codes, and received $3,553,198 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 407 prescription claims across 132 beneficiaries totaling $17,436 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 15 records totaling $51,960. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $13,046 to $17,436. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $2,681,904 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,102,740 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,815,536 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,104,389 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,087,571 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,702,674 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,860,374 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,398,293 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,586,850 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,553,198 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201590913,265$2,681,904
201687413,507$3,102,740
201783513,698$2,815,536
201887814,213$3,104,389
20191,00513,024$3,087,571
202084410,901$2,702,674
202179611,028$2,860,374
202280418,824$3,398,293
202375257,529$3,586,850
202470971,343$3,553,198

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$25K2015 Drug cost: $13,046 (USD; Tot_Drug_Cst)2016 Drug cost: $10,575 (USD; Tot_Drug_Cst)2017 Drug cost: $12,861 (USD; Tot_Drug_Cst)2018 Drug cost: $15,931 (USD; Tot_Drug_Cst)2019 Drug cost: $19,385 (USD; Tot_Drug_Cst)2020 Drug cost: $23,975 (USD; Tot_Drug_Cst)2021 Drug cost: $25,318 (USD; Tot_Drug_Cst)2022 Drug cost: $23,995 (USD; Tot_Drug_Cst)2023 Drug cost: $25,369 (USD; Tot_Drug_Cst)2024 Drug cost: $17,436 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015122324$13,046
2016104282$10,575
2017102320$12,861
2018129426$15,931
2019144465$19,385
2020154521$23,975
2021151491$25,318
2022149452$23,995
2023146431$25,369
2024132407$17,436

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1481,996$651
67028Injection of drug into eye3691,864$94
92014Established patient complete exam of visual system356394$83
92134Imaging of retina6902,273$29
J2777Injection, faricimab-svoa, 0.1 mg17263,240$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1345,753$5,933
Atropine SulfateAtropine Sulfate722,828$2,335
Bromfenac SodiumBromfenac Sodium17549$1,930
OfloxacinOfloxacin811,744$927
LatanoprostLatanoprost301,804$307

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$221Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.8$51,739Janssen Research & Development, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.1$7,384US Retina LLC

FAQ

What Medicare data is available for Andrew Glenn Cheek, MD?

Tedicare shows public-source Medicare data for Andrew Glenn Cheek, MD (NPI 1790979383), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Glenn Cheek, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Glenn Cheek, MD?

Andrew Glenn Cheek, MD is linked to SPOKANE EYE CLINIC PS (billing NPI 1730187899) in the available physician profile data.

Does Andrew Glenn Cheek, MD have Open Payments data?

Andrew Glenn Cheek, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.